Vera Therapeutics, Inc.
VERA
$34.19
-$1.09-3.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 499.16M | 596.76M | 714.59M | 497.39M | 556.83M |
| Total Receivables | 3.93M | 3.91M | 3.29M | 3.36M | 4.20M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 20.20M | 12.64M | 8.47M | 9.42M | 8.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.21M | 2.50M | 2.54M | 1.15M | 1.62M |
| Total Current Assets | 527.49M | 615.80M | 728.88M | 511.31M | 571.35M |
|
|
|||||
| Total Current Assets | 527.49M | 615.80M | 728.88M | 511.31M | 571.35M |
| Net Property, Plant & Equipment | 2.50M | 2.75M | 3.30M | 3.19M | 3.62M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 800.00K | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.19M | 3.19M | 2.55M | 3.00M | 3.55M |
| Total Assets | 532.98M | 621.74M | 734.73M | 517.50M | 578.53M |
|
|
|||||
| Total Accounts Payable | 14.57M | 13.91M | 21.90M | 17.95M | 13.16M |
| Total Accrued Expenses | 31.02M | 27.77M | 29.64M | 23.46M | 19.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 549.00K | 473.00K | 855.00K |
| Total Finance Division Other Current Liabilities | 2.73M | 3.47M | 1.37M | -- | -- |
| Total Other Current Liabilities | 2.73M | 3.47M | 1.37M | -- | -- |
| Total Current Liabilities | 48.32M | 45.15M | 53.46M | 41.88M | 33.55M |
|
|
|||||
| Total Current Liabilities | 48.32M | 45.15M | 53.46M | 41.88M | 33.55M |
| Long-Term Debt | 75.23M | 75.03M | 74.84M | 74.65M | 74.46M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.68M | 1.86M | 1.92M | 2.10M | 2.23M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 125.23M | 122.04M | 130.21M | 118.62M | 110.25M |
|
|
|||||
| Common Stock & APIC | 1.40B | 1.38B | 1.36B | 1.07B | 1.06B |
| Retained Earnings | -991.37M | -881.90M | -760.87M | -669.77M | -589.48M |
| Treasury Stock & Other | -403.00K | -156.00K | 786.00K | 881.00K | 527.00K |
| Total Common Equity | 407.76M | 499.70M | 604.52M | 398.88M | 468.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 407.76M | 499.70M | 604.52M | 398.88M | 468.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 407.76M | 499.70M | 604.52M | 398.88M | 468.28M |
|
|
|||||